December 2018

Column

Editor's Page

Where We Are With Value Assessment & Innovative Care and Reimbursement Models

12/13/2018

Winston Wong, PharmD, Editor-in-Chief

As the US health care system continues to evolve to value-based care delivery and reimbursement, questions of how to determine what treatments and models produce the most value is imperative. Stakeholders need to...

As the...

12/13/2018

Journal of Clinical Pathways

Counterpoint

Quality Measurement as a Tool for a Patient-Centered Approach to Assessing Value

12/13/2018

Tom Valuck, MD, JD

Russ Montgomery, PhD, MHS

Current quality measures usually assess performance against a standard of care for a typical patient rather than the specific patient receiving care, much like value frameworks assess value for a typical patient....

...

12/13/2018

Journal of Clinical Pathways

Viewpoint

Personalized Medicine in a World of Value Frameworks

12/13/2018

Robert W Dubois, MD, PhD

Health care treatments are becoming increasingly tailored to individual patients in terms of patient preferences and individual clinical factors. However, these tailored treatments often have a high price tag....

Health...

12/13/2018

Journal of Clinical Pathways

Pharma Insights

ACOs: Changing Health Care Cost and Quality to Be Accountable

12/13/2018

Marylou Buyse, MD, MS

Maureen Hennessey, PhD, CPCC, CPHQ

Larry Blandford, PharmD—Column Editor

Accountable care organizations (ACOs) were an innovation for Medicare following the Affordable Care Act and became the first new model of care for Medicare beneficiaries. ACOs launched in 2012-2013 could choose...

...

12/13/2018

Journal of Clinical Pathways

Clinical Pathways GPS

Value-Based Clinical Pathways in the World of Reference-Priced Medicare Part B Drugs

12/13/2018

Matthew Pakizegee, PharmD, MS

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

The Centers for Medicare & Medicaid Services (CMS) released an advanced notice of proposed rulemaking on October 25, 2018, seeking to test  whether using a combination of 3 approaches—an international drug...

The...

12/13/2018

Journal of Clinical Pathways

Editorial

2018 Editorial Index

12/13/2018

JCP Editors

Download the PDF to view the full Editorial Index of content for 2018 with articles indexed by date, author, and article type. 

...

12/13/2018

Journal of Clinical Pathways

Feature

Research Reports

The Oncology Care Model Performance Period 2 Results: Practices Are Making Some Progress, But Major Challenges Remain

12/13/2018

Charles Saunders, MD

Abstract: When launched in 2016, the Oncology Care Model (OCM) represented one of the most advanced efforts yet to migrate health care delivery from fee-for-service to fee-for-value. Practices representing nearly...

...

12/13/2018

Journal of Clinical Pathways

Perspectives

Bundled Payments: A Rising Tide for Clinical Pathways

12/13/2018

Joshua M Liao, MD, MSc, FACP

Abstract: As a value-based payment model, bundled payments represent a key component of the ongoing nationwide shift toward value-based care. The Centers for Medicare & Medicaid Services (CMS) has led the...

...

12/13/2018

Journal of Clinical Pathways

Department

Clinical Pathways Forum

The Clinical Pathways Forum: What We Do and Who Should Join

12/13/2018

Mishellene McKinney, MHA, RN, OCN

Founded in 2016, the Clinical Pathways Forum is a community of pathways professionals now totaling over 12 institutions from across the United States and Canada who are utilizing clinical pathways in their practices...

...

12/13/2018

Journal of Clinical Pathways

News

Conference Coverage

2018 San Antonio Breast Cancer Symposium

12/13/2018

JCP Editors

The 2018 San Antonio Breast Cancer Symposium (SABCS) brought together more than 7000 physicians and researchers from around the globe from December 4 through 8 in San Antonio, Texas.  SABCS began in 1977 as a...

The...

12/13/2018

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

December 2018

Column

Feature

Department

News

Current Issue

Special Reports

Subscribe

December 2018 Volume 4

Specialties

Events

Year Round Education

HMP Global Products